|Document ID (ISN)||109525|
|Convention or series no.
||IARC Monographs Volume 97
World Health Organization (WHO)
||IARC monographs on the evaluation of carcinogenic risks to humans. 1,3-Butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide)
||World Health Organization, Distribution and Sales Service, 1211 Genève 27, Switzerland, International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69372 Lyon Cedex 08, France 2008. ix, 510p. Illus. Bibl.ref. Index.
||http://monographs.iarc.fr/ENG/Monographs/vol97/mono97.pdf [in English]
||This volume re-evaluates the available evidence on the carcinogenic potential of 1,3-butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide). Ethylene oxide is widely used as a sterilizing agent for hospital equipment. The largest single use for 1,3-butadiene is in the production of styrene-butadiene rubber for tyres, while vinyl chloride is primarily used in the manufacture of polyvinyl chloride. Summary of final evaluations: ethylene oxide, 1,3-butadiene and vinyl chloride are classified in Group 1 (carcinogenic to humans); vinyl bromide is classified in Group 2A (probably carcinogenic to humans), while there is inadequate evidence for the carcinogenicity of vinyl fluoride in humans.
||WHO; IARC; vinyl chloride; fluoroethylene; vinyl bromide; ethylene oxide; hazard evaluation; carcinogenic effects; butadiene
||literature survey; chemical industry; polyvinyl chloride; criteria document; synthetic rubber industry; tyre manufacturing industry; glossary; hospitals
||E - Books, reports, proceedings
|Country / State or Province||France|
||Toxic and dangerous substances
|Broad subject area(s)
Aliphatic and alicyclic hydrocarbons